Brainsway Stock Today
| BWAY Stock | USD 10.62 0.15 1.43% |
Performance2 of 100
| Odds Of DistressOver 51
|
Brainsway is trading at 10.62 as of the 31st of January 2025; that is 1.43 percent increase since the beginning of the trading day. The stock's open price was 10.47. Brainsway has 51 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 2nd of November 2024 and ending today, the 31st of January 2025. Click here to learn more.
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 18.82 M outstanding shares of which 37.46 K shares are currently shorted by private and institutional investors with about 0.33 trading days to cover. More on Brainsway
Moving against Brainsway Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Brainsway Stock Highlights
| Business Concentration | Medical Equipment, Medical Devices, Healthcare, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Brainsway (BWAY) is traded on NASDAQ Exchange in USA. It is located in Bynet Building, Jerusalem, Israel, 9777518 and employs 134 people. Brainsway is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 204.31 M. Brainsway conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 18.82 M outstanding shares of which 37.46 K shares are currently shorted by private and institutional investors with about 0.33 trading days to cover.
Brainsway currently holds about 49.62 M in cash with 1.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.95.
Check Brainsway Probability Of Bankruptcy
Ownership AllocationBrainsway holds a total of 18.82 Million outstanding shares. Almost 80.78 percent of Brainsway outstanding shares are held by general public with 19.22 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Brainsway Ownership Details
Brainsway Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Brainsway market risk premium is the additional return an investor will receive from holding Brainsway long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0329 | |||
| Jensen Alpha | 0.0072 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | (0) |
Brainsway Stock Against Markets
Brainsway Corporate Management
| Christopher Jako | Pres CEO | Profile | |
| Ido Marom | Chief Officer | Profile | |
| Gilead Moiseyev | Chief Officer | Profile | |
| Moria Ankri | VP RD | Profile | |
| Pr Zangen | Member CoFounder | Profile | |
| Hillegonda Groen | Vice Sales | Profile | |
| Ross Mitchell | Vice Marketing | Profile |
Additional Tools for Brainsway Stock Analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.